The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.
Kei SoneharaKazunari TateishiToshirou FukushimaMasamichi KomatsuHiroshi YamamotoTomonobu KoizumiMasayuki HanaokaPublished in: Thoracic cancer (2019)
Despite a high frequency of febrile neutropenia, amrubicin salvage chemotherapy may improve OS in patients with relapsed ED-SCLC.
Keyphrases
- high frequency
- small cell lung cancer
- chemotherapy induced
- acute lymphoblastic leukemia
- transcranial magnetic stimulation
- acute myeloid leukemia
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma
- locally advanced
- emergency department
- squamous cell carcinoma
- radiation therapy
- urinary tract infection
- rectal cancer